Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications
PR Marsham, LR Hughes, AL Jackman…
Index: Marsham, Peter R.; Hughes, Leslie R.; Jackman, Ann L.; Hayter, Anthony J.; Oldfield, John; et al. Journal of Medicinal Chemistry, 1991 , vol. 34, # 5 p. 1594 - 1605
Full Text: HTML
Citation Number: 100
Abstract
The principle of effective antitumor chemotherapy with a specific inhibitor of the enzyme thymidylate synthase (TS, EC 2.1. 1.45) was established in clinical of the quinazoline-based antifolate Wo-propargyl-5, 8-dideazafolic acid (l). 4-5 The unacceptable hepatic and renal toxicities
Related Articles:
New synthesis of thymidylate synthase inhibitor raltitrexed
[Cao, Sheng-Li; Wan, Rong; Feng, Yu-Ping Synthetic Communications, 2003 , vol. 33, # 20 p. 3519 - 3526]
Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications
[Journal of Medicinal Chemistry, , vol. 34, # 5 p. 1594 - 1605]
Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications
[Journal of Medicinal Chemistry, , vol. 34, # 5 p. 1594 - 1605]
Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications
[Journal of Medicinal Chemistry, , vol. 34, # 5 p. 1594 - 1605]
Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications
[Journal of Medicinal Chemistry, , vol. 34, # 5 p. 1594 - 1605]